Brad Gescheider

Before joining Woebot Health, Brad was the Global Head of Digital Innovation and Patient Services for Sanofi’s Immunology business. In that position, he led efforts to transform the patient experience and drove a focus on broad improvement to quality of life through integrated technology delivered across the entire patient journey. As part of the service architecture redesign for Dupixent, Sanofi’s blockbuster multi-indication therapy, Gescheider built a connected SaMD (Software as a Medical Device) ecosystem to simplify and enhance the experience of onboarding and persisting on an advanced biologic therapy. Before Sanofi, Brad held senior commercial strategy and operations roles at Constant Therapy Health, GE Healthcare, McKesson and PatientsLikeMe.